Finanzen von Addus Homecare Corp (ADUS)ADUSAddus Homecare Corp

Addus Homecare Corp (ADUS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Personal Care, accounting for 78.4% of total sales, equivalent to $296.00M. Other significant revenue streams include Hospice and Home Health. Understanding this composition is critical for investors evaluating how ADUS navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Addus Homecare Corp maintains a gross margin of 31.12%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 10.32%, while the net margin is 7.31%. These profitability ratios, combined with a Return on Equity (ROE) of 9.71%, provide a clear picture of how effectively ADUS converts its operational activities into shareholder value.

In the context of the broader market, ADUS competes directly with industry leaders such as MD and NEO. With a market capitalization of $2.17B, it holds a significant position in the sector. When comparing efficiency, ADUS's gross margin of 31.12% stands against MD's 100.00% and NEO's 45.56%. Such benchmarking helps identify whether Addus Homecare Corp is trading at a premium or discount relative to its financial performance.

The company reported a revenue of $377.4 million for Q2 2026, an 8% year-over-year increase, and a net income of $27.6 million, showing solid growth. The gross margin is stable at around 31% and the forward P/E is 16.56, which is reasonable for the sector.